Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Air Liquide SA
With
Asklepios Kliniken Hamburg GmbH
the purpose of this study is to evaluate the distance walked by patients with severe Chronic Obstructive Pulmonary Disease (COPD) during a Six-Minute Walk test (6MWT) while breathing Helium/Oxygen 65%/35% compared to either breathing Nitrogen/Oxygen 65%/35% or receiving Non-Invasive Ventilation (NIV) with a FiO2 of 0.35 and to evaluate exercise related symptoms
Age
45–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female aged \>= 45 and \<= 75 years old
Patient with documented clinical diagnosis of stage III/IV COPD
Patient with stable COPD defined by no significant increase in COPD medication, no treatment for COPD in an emergency, no acute intensive care setting and no intake of antibiotics in the four weeks prior to selection
You may not be if
Inability or contra-indication to perform pulmonary function tests
Inability or contra-indication to perform the 6MWT with a trolley
Any contra-indication to receive NIV
Obese patient having a Body Mass Index (BMI) \> 35
Pregnant or lactating woman
Female or chil-bearing potential with lack of efficient contraception
Clareo Health | Six-Minute Walk Test Comparing Helium/Oxygen to Nitrogen/Oxygen for COPD Rehabilitation
